Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape

抗体同型转换作为对抗HIV中和逃逸的机制

阅读:3
作者:Cathrine Scheepers ,Valerie Bekker ,Colin Anthony ,Simone I Richardson ,Brent Oosthuysen ,Thandeka Moyo ,Prudence Kgagudi ,Dale Kitchin ,Molati Nonyane ,Talita York ,Dieter Mielke ,Batsirai M Mabvakure ,Zizhang Sheng ,Bronwen E Lambson ,Arshad Ismail ,Nigel J Garrett ,Salim S Abdool Karim ,Lawrence Shapiro ,Carolyn Williamson ,Lynn Morris ,Penny L Moore

Abstract

Neutralizing antibodies (nAbs) to highly variable viral pathogens show remarkable diversification during infection, resulting in an "arms race" between virus and host. Studies of nAb lineages have shown how somatic hypermutation (SHM) in immunoglobulin (Ig)-variable regions enables maturing antibodies to neutralize emerging viral escape variants. However, the Ig-constant region (which determines isotype) can also influence epitope recognition. Here, we use longitudinal deep sequencing of an HIV-directed nAb lineage, CAP88-CH06, and identify several co-circulating isotypes (IgG3, IgG1, IgA1, IgG2, and IgA2), some of which share identical variable regions. First, we show that IgG3 and IgA1 isotypes are better able to neutralize longitudinal autologous viruses and epitope mutants than can IgG1. Second, detrimental class-switch recombination (CSR) events that resulted in reduced neutralization can be rescued by further CSR, which we term "switch redemption." Thus, CSR represents an additional immunological mechanism to counter viral escape from HIV-specific antibody responses. Keywords: HIV; adjuvants; antibody maturation; class-switch recombination; co-evolution; isotypes; neutralization; vaccine design; viral escape.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。